SCHEMBL27631828

SCHEMBL27631828

CCOc1ccc(-c2c(N)nc(N)nc2Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ HPGD P15428 2/20 0.58
▸ DHFR P00374 6/20 0.56
▸ HEXA P06865 4/20 0.51
▸ HEXB P07686 4/20 0.51
▸ LMNA P02545 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ SLC22A1 O15245 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ HTR2A P28223 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27631954 0.78 DHFR (0.49) SMN1; SMN2KDM4EHPGDDHFRHEXA
SCHEMBL27612691 0.74 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EHPGDDHFRHEXA
SCHEMBL4410099 0.74 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EHPGDDHFRHEXA
SCHEMBL3450978 0.73 TSHR (0.51) SMN1; SMN2KDM4EHPGDDHFRHEXA
SCHEMBL5471370 0.73 NPC1 (0.54) SMN1; SMN2DHFRHEXAHEXBLMNA
SCHEMBL3451463 0.73 HSP90AA1 (0.57) SMN1; SMN2KDM4EHPGDLMNAALDH1A1
SCHEMBL27631456 0.72 DHFR (0.60) SMN1; SMN2DHFRLMNAKMT2ATDP1
SCHEMBL12487635 0.72 DHFR (1.00) SMN1; SMN2DHFRHEXAHEXBLMNA
SCHEMBL13494944 0.71 PIK3CD (0.50) SMN1; SMN2KDM4EDHFRHEXAHEXB
SCHEMBL28957216 0.70 LMNA (0.44) SMN1; SMN2KDM4EHPGDDHFRHEXA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102174024-A 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS INC 2011-09-07 — — CN disclosed
CN-1625400-B 2, 4-pyrimidinediamine compounds and uses thereof RIGEL PHARMACEUTICALS INC 2011-04-13 — — CN disclosed
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 — — CN disclosed
Send feedback